NCT07109323
- Conditions
- Cytogenetics Ultra High Risk, Disease Attributes, Disease Progression, +19 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China
Clinical trial condition
Primary Refractory
Explore clinical trials studying Primary Refractory. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study